The perinatal environment plays a crucial role in programming many aspects of adult physiology. Myriad stressors during pregnancy, from maternal immune challenge to nutritional deficiency, can alter long-term body weight set points of the offspring. In light of the increasing concern over body weight issues such as obesity and anorexia in modern societies and accumulating evidence that developmental stressors have long-lasting effects on other aspects of physiology (e.g. fever, pain), we explored the role of immune system activation during neonatal development and its impact on body weight regulation in adulthood. Here we present a thorough evaluation of the effects of immune system activation (LPS; 100 µg/kg i.p.) at postnatal day 3, 7 or 14 on long-term body weight, adiposity, body weight regulation after a further LPS injection (50 µg/kg i.p.) or fasting, and basal and LPS-induced circulating levels of the appetite-regulating pro-inflammatory cytokine, leptin. We show that neonatal exposure to LPS at various times during the neonatal period has no long-term effects on growth, body weight or adiposity. We also observed no effects on body weight regulation in response to a short fasting period, or a further exposure to LPS. Despite reductions in circulating leptin levels in response to LPS during the neonatal period, no long-term effects on leptin were seen. These results convincingly demonstrate that adult body weight and weight regulation are, unlike many other aspects of adult physiology, resistant to programming by a febrile-dose neonatal immune challenge.
INTRODUCTION
The perinatal environment is known to play a crucial role in programming body weight. In humans, low birth weight and malnutrition during gestation have been linked with abdominal obesity in adulthood (31; 45; 46) . Similarly, a variety of behavioural, physiological (including dietary manipulations) and immune stressors given to pregnant experimental animals have been reported to alter the body weight of adult offspring (4; 15; 27; 36; 40; 63) . It appears, however, that the timing of perinatal stress is critical in programming many aspects of adult physiology (35) and relatively little is known regarding the influence of postnatal stress on adult body weight regulation.
The long-term physiological consequences of a neonatal immune challenge with LPS have been extensively described by our laboratory and others. For example, we have shown attenuated febrile and associated host defence responses in adulthood to an immune challenge of the same type as that experienced at postnatal day (P) 14 (9; 17; 18) . Changes have also been demonstrated in memory processing (7) , hypothalamicpituitary-adrenal (HPA) axis activation (51; 52) and susceptibility to pathological insults in adulthood (10; 55; 56) . However, the long-term effects of a neonatal immune challenge on body weight regulation are less clear, and given the concern over the current obesity epidemic in modern society (e.g. (29) ), demand further investigation. For instance, Walker and colleagues have shown long-term changes in body weight in some cohorts of animals treated at P3 and P5 with an immune challenge, but not in others (61; 62) . In this laboratory we have observed body weight changes under the condition of experimental colitis, where P14 LPS-treated rats, as adults, lost considerably more of their body weight than did neonatally saline-treated controls in response to TNBS-colitis Page 3 of 37 Neonatal programming and body weight 4 4 (56). However, we have not seen similar changes with a P14 immune challenge under other experimental conditions (57) . These observations leave some important questions unanswered.
Total body weight, so far assessed by us only at around P70 (57) under freefeeding basal conditions, is a crude assessment of whether the rats are more or less prone to obesity or a lean phenotype. In this study we undertake a more thorough examination of total body weight changes throughout life, in both male and female rats, as well as assessing fat to muscle ratios and the weights of some important organs such as brain and adrenal glands.
The condition under which we have previously demonstrated enhanced weight loss in our P14 LPS-treated rats, experimental colitis, can be regarded as extremely stressful (28; 53) and is representative only of individuals suffering from inflammatory bowel disease, a condition in which weight loss is evident irrespective of neonatal experience (56) . In the present study we examined body weight under physiological conditions more likely to be experienced by the general population. Thus, rats were pretreated as neonates with LPS and, in adulthood, we examined their anorectic and body weight responses to a further LPS exposure. We also examined weight loss and recovery after 16 hr of food deprivation to examine the effects of stimulating the appetite.
It is evident, at least in mice, that the maturation of satiety-signalling brain regions, important for regulating food intake and averting susceptibility to obesity (43) , is initiated earlier than P14, i.e. around P7 (1; 54). Furthermore, we have previously reported that LPS-injection to group-housed P7 neonates led to a reduction in adult body weight (57) . We therefore also examined the effects of an immune challenge at different
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Neonatal programming and body weight 5 5 time points in neonatal development; P3, P7 and P14, to determine if an immune challenge at these developmental stages would alter adult body weight regulation. We deliberately selected time points bracketing P7 because of these earlier findings, and including P14 because of our previously observed programming effects on other aspects of physiology.
Long-term changes have been seen in pro-inflammatory cytokine (TNF-and IL-6) responses to LPS after an immune challenge at P14 (17) . In the present investigation, we hypothesized that any alterations in body weight or feeding as a result of a neonatal immune challenge would be reflected in changes in another pro-inflammatory cytokine, leptin. Leptin has a well-established function in satiety signalling, and its absence, whether by a mutation in the gene encoding for leptin itself (ob/ob) or in the gene encoding for the receptor (db/db), leads to an obese phenotype (30; 60) . It has also become evident that leptin is a pro-inflammatory cytokine released in response to LPS and that it plays an important role in modulating both the febrile and the anorectic responses to LPS (25; 49; 58) . We therefore also examined changes in neonatal and adult leptin levels after LPS.
Thus, in the present investigation, we hypothesized that a neonatal immune challenge at a critical point in development may have long-term programming effects on body weight. We therefore conducted a careful analysis of body weight changes and indicators of body weight regulation in Sprague-Dawley male and female rats given an immune challenge (LPS) or pyrogen-free saline (as controls) at different time points during the neonatal period.
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MATERIALS AND METHODS

Animals
Pregnant Sprague-Dawley rats (Charles River), mated between eight and nine weeks, were maintained at 22 ˚C on a 12 hr light/dark cycle (7:00 am -7:00 pm) with pelleted 575-Purina rat chow and water available ad libitum. Litters were reduced to a maximum of 12 pups two days after birth, to standardize competition for food and maternal attention and to ensure an approximately equal gender balance, and these were kept for experimentation. All procedures were conducted in accordance with the Canadian Council on Animal Care regulations and were approved by the local University of Calgary Animal Care Committee.
Neonatal LPS: effects on body weight and fasting-induced body weight changes
At P3, P7 or P14, the pups were removed from their home cage for approximately 10 min and their weight and body length (nasal to anal) measured. We randomly selected half of the male and half of the female pups in each litter to receive an intraperitoneal (i.p.) injection of a febrile dose of LPS (Escherichia coli; serotype 026:B6; Sigma, St.
Louis, MO; 100 µg/kg in 1 mL/kg pyrogen-free saline). The remaining half of the litter was given an equivalent volume of pyrogen-free saline. Ears were clipped for identification. Injections were administered between 0800 and 1000. This dose of LPS has been shown repeatedly in our laboratory to cause long-term alterations in adult physiological, behavioural and endocrine responses (9; 10; 17; 18; 55) . Four litters were used for each treatment day and approximately one or two males and females for each of the LPS and saline treatments were used from each litter, an experimental design that is Page 6 of 37 7 statistically appropriate (20) and minimizes the impact of maternal influence. At P21, all litters were weaned, the males and females separated, and the rats kept two animals to a cage and maintained on 575-Purina rat chow. Pups from the four litters from the same treatment day were combined randomly, taking care that both an LPS and a saline-treated animal was present in each cage. The rats were weighed every seven days from the day of injection until 10 weeks of age and again at 13 weeks. Length measurements were not taken after P35 as the lengths to this point were not different and the procedure requires a brief restraining of the rats, which was regarded as unnecessarily stressful. Measurements for the 13 weeks were collected from 84 animals selected from 12 litters.
At 10 weeks all rats were weighed and fasted overnight for approximately 16 hr and then weighed again to assess fasting-induced weight loss. The rats were also weighed 24 hr later to assess weight recovery. Food intake was not measured as the animals were housed more than one to a cage. After the fasting experiment, at approximately 19 weeks after birth, the rats were euthanized with an overdose of sodium pentobarbital (80-100 mg/kg i.p.) and dissected for assessment of brain, adrenal, retroperitoneal fat (left and right), and right tibialis anterior muscle weights. The tibialis anterior was chosen as a representative skeletal muscle as it has previously been shown to be altered by postnatal endotoxin given at P3 and P5 (39) . The retroperitoneal fat was chosen as it is a reliably and easily dissected representative fat pad.
Neonatal LPS: effects on adult feeding and LPS-induced anorexia
A separate group of litters was treated, at P14 only, with an i.p. injection of LPS (100 µg/kg in 1 mL/kg pyrogen-free saline) or to an equivalent volume of pyrogen-free
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Neonatal programming and body weight 8 8 saline. For this experiment we tested only P14 males as our other findings were indicating no effects of neonatal LPS, irrespective of neonatal age. We were therefore of the opinion that including the entire cohort of groups would be an unnecessarily wasteful use of animals unless some changes were found. Female pups were similarly treated and kept for use in other (separate) experiments.
At 10 weeks the rats were re-housed singly. At this time, rats were fed a standard powdered rat chow to allow for accurate measurement of daily food intake. The rats were allowed to acclimatize to the single-housing and powdered food for a period of seven days prior to the experiment. Thereafter all rats were given 50 µg/kg LPS i.p. in 1 mL/kg pyrogen-free saline or pyrogen-free saline alone at the beginning of the dark cycle. This dose was chosen as the magnitude of fever it elicits is equivalent to that produced in the neonates by 100 µg/kg (9). Body weight and food intake were assessed (by weighing the rats and remaining food) at 8 and 12 hrs post injection. This experiment was conducted on 13 rats randomly selected from 4 litters.
Neonatal LPS: acute effects on circulating leptin
At P3, P7 or P14 the pups were removed from their home cage for approximately 10 min and subjected to an i.p. injection of LPS (100 µg/kg in 1 mL/kg pyrogen-free saline) or to an equivalent volume of pyrogen-free saline. Heads were marked with permanent marker for identification. Injections were administered between 0800 and 1000. At 2.5 hr after LPS or saline administration, pups were quickly decapitated and the blood collected in heparinized tubes. Efforts were made to complete sample collection from one litter very quickly to minimize the stress effects of sequential removal of pups
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Neonatal programming and body weight 9 9 from the litter. Blood was immediately centrifuged and the plasma aliquots snap-frozen in liquid nitrogen and kept at -80 ˚C until use. In the case of the P3 animals, where the plasma yield from a single pup was very small, two to three samples from the same treatment were combined for assay. Four to six litters were used for each treatment day to avoid litter-related confounding effects. These experiments were conducted on 124 animals from 14 litters yielding 84 plasma samples.
Neonatal LPS: effects on adult leptin and LPS-induced leptin
Long-term effects of LPS on leptin were assessed using a fourth group of litters.
These were injected on P3, P7 and P14 as described above and left undisturbed, except for weaning and the usual cleaning and feeding procedures, until early adulthood. At approximately 12 weeks of age, each rat was briefly anaesthetised with halothane (induced at 4 % and maintained at 2 %) and a silicone cannula (inner diameter: 0.025 cm, outer diameter: 0.047 cm) was implanted into the jugular vein. Each cannula was filled with heparinised saline containing gentamycin. The rats were housed separately after the surgery and allowed seven days to recover before experimentation.
On the day of experimentation, the cannula was attached via polyethylene tubing to a syringe outside the housing chamber, allowing blood sampling without handling. The rats were then left undisturbed for 90 min prior to LPS injection. Cannulae were set up between 0800 and 1000. Blood samples (0.5 mL, immediately replaced with an equal volume of heparinised saline) were collected onto ice from each animal 5 min before and 2.5 hr after an i.p. injection of LPS (50 µg/kg in 1 mL/kg pyrogen-free saline). Samples 
Measurement of circulating leptin
Plasma leptin concentrations were measured using a leptin ELISA kit (LincoResearch Inc., St. Charles, MO). The inter-assay variability for this ELISA was 3.0-3.9 % CV, intra-assay variability 1.9-2.5 % CV, and the lower limit of detection was 0.04 pg/mL. All samples were assayed in duplicate.
Data analysis
Organ weight results (expressed as a percentage of total body weight) and LPSinduced body weight and anorexia, as well as adult and neonatal plasma leptin results were analysed using Student's unpaired t-tests comparing saline and LPS-treated rats at each age for males and females separately. Preliminary analysis of the neonatal leptin data showed significant (P < 0.05) gender and treatment effects within the P14 group.
However, post hoc comparisons revealed that these effects were between males and females of different neonatal treatments. This mixed interaction was not associated with the primary hypotheses of the present experiments, and thus we decided to analyze all of our data in separate gender groups specific for age. Scores for body weights and lengths were compared using a one-way ANOVA with repeated measures (RM), with injection (LPS or saline) as the between factor, and time from treatment (week) as the RM for each of the P3, P7 and P14 treatment days for males and females. Scores for the fasting / recovery experiment were compared using a one-way ANOVA with RM, with injection
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Neonatal programming and body weight 11 11 as the between factor, and time as the RM for each of the treatment days for males and females. In each case statistical significance was assumed when P < 0.05. Data are presented as mean ± standard error of the mean.
RESULTS
Neonatal LPS: effects on body weight, fasting-induced body weight changes and
LPS-induced anorexia
To determine if neonatal LPS caused long-term programming effects on body weight, we monitored body weight and growth, as well as appetitive and body weight responses in the adult to fasting and inflammation. Body weights measured to 13 weeks were not affected by neonatal treatment at any of the three ages in either males or females ( Fig. 1 A, B ; n = 5-8 per group; for this and subsequent data, rats are representatives of four to six litters per neonatal treatment age). Nasal-anal lengths measured to five weeks were also very similar between groups (Fig. 1 C, D) . Although statistical comparisons were not made (see 'data' section of methods), male and female rats were very similar in body weight while together as a litter and the males, as expected, started to outgrow their female counterparts approximately two weeks after weaning.
The possibility of similar body weights masking differences in fat to muscle ratios was explored by examining the post-mortem weights of the retroperitoneal fat pads and the tibialis anterior. No differences were found in the fat to muscle ratios between any of the treatment groups for males or females either in absolute values (data not shown) or when expressed as a percentage of body weight ( Fig. 2 ; n = 4-8 per group). No differences were found in either fat or muscle weights expressed independently (data not Page 11 of 37 12 shown). Furthermore, no differences were seen in brain or adrenal gland weight between any of the groups (Table 1) .
We further asked if a challenge in the form of food deprivation or immune stimulation would differentially affect rats given LPS or saline as neonates. The same rats as described above were deprived of food for 16 hr overnight. All the rats, irrespective of gender or treatment group lost between 5.4 and 6.6 % of their body weight during the fasting period and had gained this weight back again by 24 hr later (Fig. 3 A, B ; n = 5-8 per group).
In addition, no differences were seen in LPS-induced body weight changes or LPS-induced anorexia between adult males treated with LPS at P14 and the P14 salinetreated controls ( 
Neonatal LPS: acute effects on circulating leptin
Given no differences in body weight, growth or in fasting or sickness-induced body weight changes, we wanted to also discount the possibility of more subtle changes to satiety signalling during the neonatal period. Because of the role of leptin in both Page 12 of 37 modulation of immune responses and in regulating food intake, we therefore measured basal and LPS-induced plasma leptin immediately after a neonatal injection of LPS. In the neonatal males, basal (saline-treated) circulating leptin levels were approximately 2000 pg/mL at all three age groups, and values were similar irrespective of age. In the females basal levels tended to be higher, approximately 3000 pg/mL, at P3 and P7, and lower, approximately 1800 pg/mL, at P14 (Fig. 4 ; n = 5-12 per group). LPS-treatment (n = 5-16 per group) did not further elevate these levels in either males or females.
However, a significant decrease in plasma leptin was seen with LPS in females at both P3 (t = 2.412, P = 0.037) and P14 (t = 2.374, P = 0.040) with a trend in the same direction at P7 (t = 1.675, P = 0.128; Fig. 4 ). In the males no significant differences with LPS treatment were seen. However, there was a substantial trend towards a difference at P3 (t = 2.016, P = 0.069).
Neonatal LPS: effects on adult LPS-induced leptin
We also examined potential programming effects of a neonatal neuroimmune challenge by measuring basal and acute LPS-induced leptin levels in adulthood. Our results reveal no effects of a neonatal immune challenge at any of the ages tested on adult leptin levels, either basal or LPS-stimulated, in either males or females ( Fig. 5 ; n = 4-7 per group).
DISCUSSION
In the present series of experiments we have convincingly demonstrated that a neuroimmune challenge during the early postnatal period, at least at the time points and Page 13 of 37 14 dose tested here, does not significantly affect growth and body weight of the male or female rat. In addition to basal growth and body weight, we tested changes in weight in response to a brief fasting period, as well as body weight and food intake to a febrile dose of LPS. We found identical responses irrespective of neonatal treatment.
Our findings, in light of the existing literature, indicate that while a prenatal immune challenge may affect subsequent body weight and growth, rats do show a resistance to programming effects of a similar challenge experienced postnatally. Other groups have shown that maternal exposure to multiple injections of endotoxin or some cytokines can lead to increases in body weight, adiposity and circulating leptin levels in the offspring (15; 40; 63) . In contrast, multiple endotoxin administration during the very early postnatal period (at P3 and P5) has been reported to result in a very slight reduction (62) or no change (39; 61) in total body weight. We have now extended this neonatal period to time points that are very sensitive to other programming aspects and still find no effect on weight. It is possible that animals raised under different environmental conditions may display vulnerabilities in terms of their weight regulation that are not evident in our cohort of animals raised under standard husbandry conditions. For example, in the Walker study (62), the rats were housed singly, and neonatal LPS can, under some circumstances, affect adult weight in housing situations of four or more rats (57) .
While it is yet preliminary to conclude that neonatally LPS-treated rats would not respond differently to other challenges to their appetite and weight regulation, we did not see differences with the challenges used here. As mentioned in the introduction, we have previously seen altered weight loss as a result of experimental colitis after P14 LPS.
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However, this stimulus is one which is relatively chronic, causing weight loss for at least four days after treatment. It also directly affects the gastrointestinal tract, probably involving mechanisms of weight loss independent of, or in addition to, suppression of appetite and feeding (56) .
There is now considerable evidence that neonatal leptin, although most likely not acting as a satiety factor as it is known to in the adult, may be very important in maturation of the hypothalamic regulatory circuits involved in appetite regulation (1; 11-13; 37; 44; 54). Thus we were very interested in determining if neonatal administration of LPS altered neonatal leptin levels. Previous reports indicate transient high neonatal leptin levels in mice (1; 16) and in Zucker fa/fa rats (47) . However, we did not see that here and, at the three times we collected plasma, leptin levels in the neonates were similar to what we measured in ad libitum fed adult rats. It has previously been demonstrated, at least in adult rodents, that a neuroimmune challenge in the form of a high dose of LPS can cause a two to three fold increase in circulating leptin levels (6; 23; 33; 34; 50) . It is interesting to note that, in our experiments, instead of causing an increase in circulating leptin, as we expected given these previous findings in adults, LPS during the neonatal period reduced circulating leptin levels. This was particularly true of the females, while the males did not show a significant response to LPS. While rats are still suckling, the majority of their leptin comes directly from the mother through the milk (42) , and it could be suggested that the leptin reduction we see in these rats is due to a sickness-induced decrease in food intake, possibly due to reduced success in competition for food with healthy littermates. However, there is no evidence that LPS-exposed neonates suckle less or receive less maternal attention than their saline injected littermates at the times we This reduction in plasma leptin could therefore reflect a reduction in the contribution coming from the pups themselves via an as yet unknown mechanism or an alteration in the absorption of leptin from the gastric tract (2) . Whatever the mechanism of this significant reduction in circulating leptin, especially in the females, there appears to be no resulting alterations in related adult physiology, suggesting that the change in leptin we see here is either too short-lived or too small to result in long-term alterations.
Rats given LPS as adults show well-documented increases in circulating levels of the pro-inflammatory cytokines TNF and IL-6 (8; 17; 19) . We have previously demonstrated significant reductions in the levels of the LPS-stimulated pro-inflammatory cytokines in LPS-treated adults given LPS at P14 (17). Thus we were very interested in determining if leptin levels, which can also be increased after LPS (6; 23; 33; 34; 50) , are similarly reduced. However, we did not see any increase in leptin with the dose of LPS used (50 µg/kg) in the adult rats. This dose was deliberately selected as we have previously used the same to demonstrate alterations in other systems such as neuroimmune regulation and pain perception with a neonatal immune challenge (9; 10; 17; 18; 57) . It is possible that either our dose of LPS to induce leptin release into the plasma is too low or that our time point for plasma sampling (2.5 hr) is not optimal. For example, in the earlier studies in which LPS injection was shown to cause elevations in leptin, doses were either much higher -in a range known to produce sepsis; 5 mg/kg i.p.
(6) or 150 -600 µg/kg intravenous (33; 34) to rats or 1 mg/kg i.p. to mice (50) . Thus, the Page 16 of 37 present study does not rule out a potential long-lasting effect of higher doses of LPS on body weight. Also, in some cases, plasma samples were taken much later 4 -5 hr (6; 50).
In the few studies where circulating leptin has been altered by high doses of LPS and plasma measured earlier, effects have been shown to occur by approximately 2 hr (34), thus at approximately the same time as our sampling. Also in agreement with our findings, another recent study reported no elevation in plasma leptin levels in rats after 250 µg/kg LPS (22) . It is difficult to understand therefore why, in several recent studies (25; 26; 49) , febrile and anorectic effects induced by 100-250 µg/kg LPS were abrogated or reduced at similar time points by leptin antiserum. Further investigation will be required to determine how leptin antiserum can alter LPS-induced variables in the absence of a change in circulating levels. Exploration of these issues is beyond the scope of this communication but may provide fruitful avenues for future investigation.
In the present study we investigated rats of young (P70) to mid (P133) adulthood and it could be argued that neonatal LPS may have programming effects that are revealed in later adulthood or old age. This suggestion is unlikely to be the case, however. Rats at P70 can be regarded as adults in the sense that they are sexually mature (32; 41) and capable of reproducing and successfully raising pups. Furthermore, body weight during childhood, adolescence and early adulthood is an excellent predictor of body weight and propensity to obesity in later life (38; 59), even in humans (14; 21; 24) . We are therefore confident that the lack of a programming effect of neonatal immune challenge we see in young adults is indicative that there would be a similar lack of effect on phenotype in later age.
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The questions examined in the present investigation have significant relevance to human health and the impact of perinatal events on long-term phenotype is important. Therefore, it is essential to note that it is difficult to equate rat developmental stages with those of humans. It has been estimated that the rat brain at postnatal days 7-13 is approximately equivalent developmentally to the human brain at birth (5; 48) and therefore the time points selected in this study may more closely reflect that of at or around birth in humans.
Together these data convincingly indicate that the programming effects of a febrile dose of LPS do not affect all components of the host defence response in the adult. 
